stable bpc-157 arginate CAPSULES BPC 157 Arginate UK: Acetate,

doi: 10.3390/jcm10051081 58

0.25 mg per injection Weeks 1 4 Frequency 1 / week Monthly Total 1.0 mg Purpose GI adaptation 0.25 mg/wk 0.5 mg per injection Weeks 5 8 Frequency 1 / week Monthly Total 2.0 mg Purpose Dose escalation 0.5 mg/wk 1.0 mg per injection Weeks 9 12 Frequency 1 / week Monthly Total 4.0 mg Purpose Therapeutic range 1.0 mg/wk 1.7 mg per injection Weeks 13 16 Frequency 1 / week Monthly Total 6.8 mg Purpose Continued escalation 1.7 mg/wk 2.4 mg per injection Week 17 onward Frequency 1 / week Monthly Total 9.6 mg Purpose Maintenance dose 2.4 mg/wk Pick Your Injection Day Cagrilintide is injected once per week on the same day

This naturally occurring copper peptide was first identified in human plasma and has been studied for decades

Low NAD+ undermines the very system MOTS-c is trying to support